BSE filing, NSE: HARIGOV. Summary written from the filing by ALFA Finder's alert engine.
Popees Baby Care India Ltd: key numbers
- Share price
- ₹117.70
- Market cap
- ₹92.48 Cr
- Revenue (annual)
- ₹2.60 Cr
- Net profit (annual)
- ₹0.09 Cr
- P/E (TTM)
- 128.7×Sector 49.5×
- Promoter holding
- 72.17%+0.02% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Popees Baby Care India Ltd
All →Popees Baby Care India Preferential Issue
Popees Baby Care India allotted equity shares and warrants at Rs 142, raising about Rs 511.33 Crore. Paid-up capital rises to Rs 44.25 Crore.
- Value
- ₹511.3 Cr
Popees Baby Care India Acquisition Worth ₹508.8 Cr
Popees Baby Care India's board approved a share-swap acquisition of Popees Baby Care Products using equity shares and warrants. Shareholder approval is pending at an EGM.
- Value
- ₹508.8 Cr
Popees Baby Care India Board Meeting Date
Popees Baby Care India Limited has scheduled a board meeting for 24th October 2026 to discuss modifying a preferential issue proposal and extending its EGM date.
Popees Baby Care India Promoter Reclassification
Popees Baby Care India submitted an application to BSE seeking no-objection for reclassifying two promoters to Public category. The move shifts ownership classification without changing shareholding percentages.
Popees Baby Care India Fund Raise of ₹511.3 Cr
Popees Baby Care India Limited board approved a preferential issue of equity shares and warrants totalling ₹511.33 Crore, pending shareholder approval on November 18, 2026.
- Value
- ₹511.3 Cr
- Execution
- 18 months
Popees Baby Care India Acquisition Worth ₹511.3 Cr
Popees Baby Care India Ltd approved the acquisition of 99.31% stake in Popees Baby Care Products Ltd via a share swap arrangement, alongside a preferential share issuance.
- Value
- ₹511.3 Cr
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.